WeedMD and Starseed Medicinal Launch Combined Medical Sales Marketplace with Expanded Cannabis Product Offerings
Medical cannabis dried flower, oils, vaporization products and softgel capsules now available to all registered patients under one simplified online sales system
Toronto, Canada, September 22, 2020 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of adult-use and medical cannabis, is pleased to announce it has merged its online medical product marketplaces under one platform and expanded its product offerings. The simplified Starseed Medicinal Inc. sales platform provides the Company’s patients with full access to WeedMD-produced dried flower, oil concentrates, softgel capsules and Aurum vaporization (vape) products and services such as same-day delivery.
WeedMD, as the cultivator and producer will complete its full patient migration to its wholly-owned streamlined Starseed Medicinal online marketplace by early October, 2020. Once merged, all patients will have access to the Company’s product offerings including access to Mary’s Medicinals topicals gels and creams slated to roll out later this year.
“Providing our patients with equal access to our products under one marketplace is an important part of integration that demonstrates our commitment to our medical roots whilst bringing cost advantages that will be re-directed to product innovation and patient services,” said Angelo Tsebelis, CEO, WeedMD. “Starseed’s online medical marketplace, which is widely recognized for its revolutionary portfolio and sales distribution channels, aims to consistently deliver WeedMD quality-cultivated products to all our valued patients.”
“Uniting our medical channel under one marketplace provides our patients with a promise of unparalleled access to more strains, a diverse selection of product formats including vapes and soon, Mary’s topical gels and creams,” said Moe Jiwan, Chief Customer Officer, WeedMD. “It also includes ease of access to our patient services with same-day shipping and delivery, access to a robust network of healthcare professionals, a client care team available seven days a week and direct billing to insurance providers. Moving forward, we will continue to open product channels to our medical patients first as we introduce strain-specific formats derived from some of our most popular genetics at an optimum price point.”
Unique Pharmacy Model
WeedMD’s unique Starseed-medical marketplace is a revolutionary Canadian system built around a virtual pharmacy-model. It’s one-of-kind proprietary technology takes online orders and intuitively completes direct billing adjudication and processing where applicable. Additionally, the products on its Starseed marketplace carry Product Identification Numbers (PINs) allowing health-care practitioners, pharmacists, patients and insurers a greater understanding of how medical cannabis can be utilized.
The Company’s NorthStar Wellness clinic will be assisting with the complementary patient migration. Find more information about patient registration and sign up details here.
About WeedMD Inc.
WeedMD Inc. is the publicly traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully-licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed, a medical-centric operator, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well, as seven provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.
Follow WeedMD on LinkedIn
Twitter: WeedMD, Color Cannabis, Saturday Cannabis & Starseed
Instagram: WeedMD, Color Cannabis, Saturday Cannabis & Starseed
For further information, please contact:
For Investor Enquiries:
Valter Pinto
Managing Director
KCSA Strategic Communications
1-212-896-1254
weedmd@kcsa.com
For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
416-897-6644
marianella@weedmd.com
All product images and labels are provided for information and illustrative purposes only, and do not represent the actual cannabis product, product label, or its appearance.
Forward Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR a www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE